Close
Close
Finance News

ProQR to Present at the Annual Piper Jaffray Healthcare Conference

3.0
3.0 from 2 votes
Wednesday, November 22, 2017

LEIDEN, the Netherlands - ProQR Therapeutics N.V.(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases including cystic fibrosis, Leber's congenital amaurosis 10 and dystrophic epidermolysis bullosa, announced that Smital Shah, Chief Financial Officer, will take part in a fireside chat during the 29th Annual Piper Jaffray Healthcare Conference on Wednesday, November 29, 2017 at 3:00pm ET. The conference is being held at the Lotte New York Palace in New York, NY.

The live and archived audio webcast of the fireside chat will be accessible from the 'Investor Relations' section of ProQR's website (www.proqr.com) under 'Events and Presentations'. The archived webcast will be available for 30 days following the presentation date.

About ProQR

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis 10 and dystrophic epidermolysis bullosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.
*Since 2012*

Contact:

ProQR Therapeutics N.V.:
Investor and Media Contact:
Bonnie Ortega
T: +1 858 245 3983
ir@proqr.com

Source: ProQR Therapeutics N.V.
3.0
3.0 from 2 votes
Free Newsletter
Videos